Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
The weight loss jab has become a blockbuster pharmaceutical hit, with people, including the diabetics it was originally ...
A study has found the anti-obesity drug sold under brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks, strokes ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular weight-loss drug.
An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...
Semaglutide, known by its brand name Wegovy, has become a popular weight loss tool. Here’s how it works, and the risks to ...
Global obesity rates have nearly tripled since 1975, per WHO and Goldman Sachs. The growing usage of GLP-1 drugs in weight ...
Share on Pinterest Researchers say weight-loss medications such as Ozempic can help with heart health as well as long-term ...